-+ 0.00%
-+ 0.00%
-+ 0.00%

BofA Lifts Banca Mediolanum EPS Estimates Post-Q3 Results; Buy Maintained

MT Newswires·11/18/2026 12:43:10
Listen to the news
12:43 PM EST, 11/18/2026 (MT Newswires) -- BofA Global Research revised its EPS estimates for Banca Mediolanum (BMED.MI) following the Italy-based financial services company's third-quarter results. "We reiterate our Buy rating and PO of EUR25.50 as 2026-28 EPS rises 1-3% for stronger NII guidance (+20% YoY in 2026, +10% in 2027). We also increase 2026 DPS to EUR1.00 (4% yield) which now includes a special DPS of EUR0.15 for higher expected performance fees," the research firm said in a European Asset Management report focused on Italian companies published Wednesday. For 2026 and 2027, EPS forecasts were increased to 1.67 euros and 1.61 euros, respectively, from 1.62 euros, and 1.59 euros. "Despite record managed inflows in2026, BMED expects 2027 to be better driven by a growing network, increased banker productivity, instalment plans, deposit conversion, new pension products, etc. Sustained flows support BMED's re-rating while EPS momentum continues," BofA added.